Artificial Intelligence by Veeva: Advantages, Drawbacks, and Strategies for Businesses to Adjust
In the realm of life sciences, Veeva Systems is making strides in integrating Artificial Intelligence (AI) into its Vault Platform and applications. This move is set to revolutionise business operations in clinical, commercial, regulatory, quality, medical, and safety programmes.
By the end of 2025, Veeva is set to introduce AI Agents and AI Shortcuts, providing application-specific AI with secure access to Vault data, documents, and workflows. These tools will offer nuanced and context-aware responses to support various functions within the organisations [1].
Since 2019, Veeva has already incorporated AI in Vault Auto Claims Linking to enhance content development speed and compliance, and in 2020 in Veeva CRM Approved Notes for customer relation insights and compliance risk detection [1].
The AI-enhanced Clinical Data Management System (CDMS) improves the accuracy and speed of source data verification (SDV), focusing clinical research associates (CRAs) on critical data points. Similarly, AI streamlines regulatory document management in SiteVault, reducing administrative burden and speeding up study start-up [2].
Quality teams can use Vault Quality AI agents and shortcuts to reduce manual documentation time, support risk mitigation, and identify CAPA trends for continuous improvement. The integration across quality, regulatory, clinical, and safety functions enhances decision-making and operational alignment [2][5].
Commercial teams can benefit from AI capabilities by improving sales rep efficiency in planning and managing HCP relationships through the Commercial Cloud and Data Cloud [3].
The benefits of Veeva AI integration are manifold. It improves operational efficiency by automating routine tasks, reducing manual workload, and accelerating processes. AI also enhances data interpretation, enabling life sciences companies to better understand complex datasets, enabling faster and more informed decisions [1][5].
However, the implementation of AI carries inherent risks. Ensuring secure access to sensitive Vault data is critical to prevent unauthorized use or breaches. Aligning AI tools with strict regulatory standards requires careful planning and validation. Organisations must manage the cultural and operational shifts AI introduces, including training and adapting workflows [1].
To prepare for the use of Veeva AI, it's critical to assess the current state of operations, compare that with business goals, compliance needs, and future state. Defining clear operational goals, assessing and structuring data, aligning with compliance, investing in change management, and leveraging Veeva Business Consulting can help organisations effectively implement AI [1][5].
In the near future, Veeva plans to release two new AI bots: Vault CRM Bot and MLR Bot for Vault PromoMats. The MLR Bot will be used as a solution for regulatory affairs and marketing teams to accelerate and standardize medical, legal, and regulatory review processes in the Vault PromoMats environment [4].
In conclusion, Veeva's expanding AI capabilities promise significant advancements in efficiency, data insight, compliance, and speed across all key life science functions. However, to realise their full potential, organisations should proactively define goals, ensure data quality, manage compliance rigorously, and invest in change management.
- Veeva Systems, in the life sciences sector, is pioneering the integration of Artificial Intelligence (AI) into its Vault Platform and applications, revolutionary for business operations in clinical, commercial, regulatory, quality, medical, and safety programmes.
- By 2025, Veeva will introduce AI Agents and AI Shortcuts, offering application-specific AI with secure access to Vault data, documents, and workflows to support various organisational functions.
- Since 2019, Veeva has integrated AI into Vault Auto Claims Linking for enhanced content development speed and compliance, and in 2020 into Veeva CRM Approved Notes for customer relation insights and compliance risk detection.
- The AI-enhanced Clinical Data Management System (CDMS) by Veeva improves the accuracy and speed of source data verification (SDV), and AI streamlines regulatory document management in SiteVault.
- Quality teams can use Vault Quality AI agents and shortcuts for reducing manual documentation time, supporting risk mitigation, and identifying CAPA trends for continuous improvement, while integration across functions enhances decision-making and operational alignment.
- Commercial teams can benefit from AI capabilities by improving sales rep efficiency in planning and managing HCP relations through the Commercial Cloud and Data Cloud.
- The implementation of Veeva's AI solutions comes with inherent risks, such as ensuring secure access to sensitive Vault data and aligning AI tools with strict regulatory standards. Organisations must manage cultural and operational shifts, including training and adapting workflows.
